Tech Company Financing Transactions

Deciphex Funding Round

Seroba Life Sciences and private investors participated in a $4.2 million funding round for Deciphex. This venture round was announced on 1/25/2023.

Transaction Overview

Company Name
Deciphex
Announced On
1/25/2023
Transaction Type
Venture Equity
Amount
$4,240,000
Round
Undisclosed
Investors

Seroba Life Sciences (Lead Investor)

private investors (Jennifer McMahon)

Proceeds Purpose
The company intends to use the funds to continue developing its products and services, to expand its presence in the UK, Canada, the Middle East and the US, and to strengthen its position in the field of digital pathology and AI.

Company Information

Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
1012 95th St. Naperville
Chicago, IL 60564
USA
Phone
708 573 0674
Website
www.deciphex.com
Email Address
[email protected]
Overview
Patholytix is the industry-leading digital pathology workflow & integrated AI platform for Research Pathology. Patholytix is trusted by the leading CROs and pharmaceutical companies for handling high volume drug safety pathology studies, providing a complete GLP-compliant workflow with integrated AI screening capabilities.
Profile
Deciphex LinkedIn Company Profile
Social Media
Deciphex Company Twitter Account
Company News
Deciphex News
Facebook
Deciphex on Facebook
YouTube
Deciphex on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Donal O'Shea
  Donal O'Shea LinkedIn Profile  Donal O'Shea Twitter Account  Donal O'Shea News  Donal O'Shea on Facebook
Chief Medical Officer
Runjan Chetty
  Runjan Chetty LinkedIn Profile  Runjan Chetty Twitter Account  Runjan Chetty News  Runjan Chetty on Facebook
Chief Operating Officer
Mairin Rafferty
  Mairin Rafferty LinkedIn Profile  Mairin Rafferty Twitter Account  Mairin Rafferty News  Mairin Rafferty on Facebook
Vice President
Luke Benko
  Luke Benko LinkedIn Profile  Luke Benko Twitter Account  Luke Benko News  Luke Benko on Facebook
VP - Bus. Development
John Nolan
  John Nolan LinkedIn Profile  John Nolan Twitter Account  John Nolan News  John Nolan on Facebook
VP - Sales
Colin Doolan
  Colin Doolan LinkedIn Profile  Colin Doolan Twitter Account  Colin Doolan News  Colin Doolan on Facebook

 

 

Browse more venture capital transactions:

Prev: 1/25/2023: Speakeasy Co. venture capital transaction
Next: 1/25/2023: Injective Protocol venture capital transaction

 

Share this article

 

About Our Venture Capital Transactions Database

We do our best to report on every notable VC transaction. All VC database entries reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.